Luminopia significantly improved control of intermittent exotropia in a pilot study of younger children, according to a press release.“While this is a small pilot study, the combination of improved motor control and a signal in sensory fusion suggests that dichoptic therapy warrants further investigation in larger controlled trials,” Shelley Hancock, senior director of medical affairs at Luminopia, told Healio.The study included 10 children between the ages of 4 and 7 years old who were treated with Luminopia for 3 months and checked again after a 3-month washout period. They were
